Skip to content

Season 6, Episode 2 - Why do we need HBV functional cure?

In this episode, the panellists will evaluate past efforts, current trials, and the evolving landscape of HBV cure research. They will also weigh the patient-friendliness of these strategies, exploring potential pathways to a cure. How will the landscape of trials and research methodologies evolve in the future to facilitate this quest?

Faculty: Ahmed Elsharkawy (Moderator), Markus Cornberg (Faculty), Dickens Theodore (GSK Representative), Su Wang (Faculty)

This EASL Studio is supported by GSK.

Related episodes:


Back To Top